1. Home
  2. CRL vs WAY Comparison

CRL vs WAY Comparison

Compare CRL & WAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRL
  • WAY
  • Stock Information
  • Founded
  • CRL 1947
  • WAY 1999
  • Country
  • CRL United States
  • WAY United States
  • Employees
  • CRL N/A
  • WAY N/A
  • Industry
  • CRL Biotechnology: Commercial Physical & Biological Resarch
  • WAY
  • Sector
  • CRL Health Care
  • WAY
  • Exchange
  • CRL Nasdaq
  • WAY Nasdaq
  • Market Cap
  • CRL 7.1B
  • WAY 6.7B
  • IPO Year
  • CRL 2000
  • WAY 2024
  • Fundamental
  • Price
  • CRL $157.12
  • WAY $39.34
  • Analyst Decision
  • CRL Hold
  • WAY Strong Buy
  • Analyst Count
  • CRL 14
  • WAY 14
  • Target Price
  • CRL $186.38
  • WAY $42.23
  • AVG Volume (30 Days)
  • CRL 859.6K
  • WAY 1.7M
  • Earning Date
  • CRL 08-06-2025
  • WAY 08-06-2025
  • Dividend Yield
  • CRL N/A
  • WAY N/A
  • EPS Growth
  • CRL N/A
  • WAY N/A
  • EPS
  • CRL N/A
  • WAY 0.15
  • Revenue
  • CRL $4,022,597,000.00
  • WAY $975,192,000.00
  • Revenue This Year
  • CRL N/A
  • WAY $8.95
  • Revenue Next Year
  • CRL $2.49
  • WAY $9.44
  • P/E Ratio
  • CRL N/A
  • WAY $256.67
  • Revenue Growth
  • CRL N/A
  • WAY 18.25
  • 52 Week Low
  • CRL $91.86
  • WAY $20.26
  • 52 Week High
  • CRL $254.15
  • WAY $48.11
  • Technical
  • Relative Strength Index (RSI)
  • CRL 67.60
  • WAY N/A
  • Support Level
  • CRL $148.41
  • WAY N/A
  • Resistance Level
  • CRL $160.40
  • WAY N/A
  • Average True Range (ATR)
  • CRL 4.71
  • WAY 0.00
  • MACD
  • CRL 0.42
  • WAY 0.00
  • Stochastic Oscillator
  • CRL 81.08
  • WAY 0.00

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About WAY Waystar Holding Corp. Common Stock

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.

Share on Social Networks: